Zugriffe | |
---|---|
Safety and efficacy of ruxolitinib in an open-label, multicenter, single-arm phase 3b expanded-access study in patients with myelofibrosis | 259 |
Oktober 2023 | November 2023 | Dezember 2023 | Januar 2024 | Februar 2024 | März 2024 | April 2024 | |
---|---|---|---|---|---|---|---|
Safety and efficacy of ruxolitinib in an open-label, multicenter, single-arm phase 3b expanded-access study in patients with myelofibrosis | 1 | 1 | 1 | 1 | 3 | 1 | 6 |
Zugriffe | |
---|---|
1065.full.pdf | 139 |